Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06101966

A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy

A Novel Predictive Model and Risk Stratification for Early Metastasis in Cervical Cancer Patients After Radiotherapy

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Fujian Cancer Hospital · Other Government
Sex
Female
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.

Detailed description

Some cervical cancer patients experienced distant metastasis quickly after receiving complete radiotherapy and have a worse prognosis. However, there were few studies focused on these patients and with early distant metastasis. It is significant to predictive and screen out cervial cancer patients with a high risk of early metastasis for more comprehensive treatments and follow-up plans

Conditions

Interventions

TypeNameDescription
RADIATIONexternal pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)Radical RT consisted of external pelvic beam radiotherapy (EBRT) and individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT).Cisplatin-based concurrent chemoradiotherapy (CCRT) was recommended for CC patients unless for economic status, age consideration and patients' desires.

Timeline

Start date
2023-12-01
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2023-10-26
Last updated
2023-10-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06101966. Inclusion in this directory is not an endorsement.